Enliven Therapeutics, Inc. (ELVN) Free Cash Flow
Enliven Therapeutics, Inc. (ELVN) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2020-12-31 | -$37.42M |
| 2021-12-31 | -$19.32M |
| 2022-12-31 | -$32.69M |
| 2023-12-31 | -$61.42M |
| 2024-12-31 | -$73.24M |
| 2025-12-31 | -$70.46M |
How ELVN compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| VTGN | Vistagen Therapeutics Inc. | -$66.44M |
| ALT | Altimmune Inc. | -$67.55M |
| LXRX | Lexicon Pharmaceuticals Inc. | -$67.85M |
| QTRX | Quanterix Corporation | -$79.85M |
| ABEO | Abeona Therapeutics Inc. | -$84.30M |
These are five companies in the same sector as ELVN with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Enliven Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("ELVN", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ELVN | $57.86 | -4.36% | 0.58M |
| 3 | ||||
| 4 | ||||
| 5 |